Members
Education: Cand. Polit., Economics.
Other directorships: Chairman of the Board The Fertility Partnership Ltd and Tandlægen.dk - Holding A/S. Ordinary board member in 3Shape A/S, Sonion A/S and Colony ApS. Former senior positions at Demant A/S, including President Demant Inc.
Independent of company and major shareholders.
Education: BSc Medicine, MSc Bioengineering, BSc Mathematics, Ph.D. Neurophysiology, Ph.D. Engineering (hc), Graduate from Swedish armed forces language school.
Other directorships: President/CEO of EQL Pharma AB (publ). Chairman of the Board Bionamic AB. Board member Flatfrog Laboratories AB, Reccan AB, EQL Pharma AB (publ), Amniotics AB (publ), and Gasporox AB (publ). Founder of EQL Pharma AB and Flatfrog Laboratories AB, among others.
Dependent on major shareholders.
Education: BSc Business Administration, degree in journalism.
Other directorships: CFO at Addnode Group. Former experiences include CFO of Acando and Protect Data and authorized auditor at PwC.
Independent of company and major shareholders.
Education: M.Sc. Chemical Engineering.
Other directorships: Chairman of the Board Artificial Solutions AB and Tobii Dynavox AB. Member of the board of Nolato AB, Industrifonden AB, Crad AB, and Biotage AB. Former senior positions at Elekta AB, Siemens Healthcare, and Gambro.
Independent of company and major shareholders.
Education: Biological Laboratory Science.
Other directorships: CEO of The Binding Site Group Ltd. Former experiences include CEO of Hemostasis, Hematology, and Specialty Diagnostics at Siemens Healthineers and Division President of Clinical Diagnostic Division at Thermo Fisher Scientific.
Independent of company and major shareholders.
Education: PhD Applied Mathematics.
Employed since 2000. Current position, Product Manager.
Board member appointed by the unions 2022.
Education: MSc Mechanical Engineering.
Employed since 2018. Current position, Mechanical Engineer, Hardware department, Devices & Software division.
Board member appointed by the unions 2021.
Nomination Committee
Ahead of the Annual General Meeting in 2023, the Nomination Committee consists of: Christer Fåhraeus (appointed by Christer Fåhraeus with Companies), Nicklas Hansen (appointed by William Demant Invest A / S), Anette Andersson (appointed by SEB Investment funds), and Emil Hjalmarsson (appointed by Grenlunden CEVI AB).
Shareholders wishing to submit proposals to the Nomination Committee can email ir@cellavision.com or ordinary mail to: The Nomination Committee, CellaVision AB, Mobilvägen 12, 223 62 Lund.
Audit & Remuneration Committees
Audit Committee
The CellaVision Audit Committee was appointed within the Board in 2011. The committee comprises Åsa Hedin, Mikael Worning, and Ann-Charlotte Jarleryd (Chairman).
Remuneration Committee
The CellaVision Remuneration Committee was appointed within the Board in 2011. The committee comprises Mikael Worning (Chairman), Åsa Hedin, and Christer Fåhraeus.